Page 4,594«..1020..4,5934,5944,5954,596..4,6004,610..»

RoosterBio Inc, a Frederick Maryland Biotech Startup, Achieves Rapid Traction with Product Launch and Fundraising …

Posted: Published on February 26th, 2014

Frederick, MD (PRWEB) February 25, 2014 RoosterBio Inc is a new biotech start-up supplying human bone marrow-derived Mesenchymal Stem Cells (hBM-MSC) for tissue engineering research and stem cell-based product development into the high growth Synthetic Biology and Regenerative Medicine fields. RoosterBio, Inc. initiated laboratory operations in October, 2013, and has achieved the critical milestone of first product shipment to paying customers in just four short months. In addition to the early validation of their business model and rapidly generating revenue, Roosterbio has raised over 250K in seed investment and are actively seeking funds via AngelList (https://angel.co/roosterbio). RoosterBio credits their quick-to-market accomplishments to hyper-efficient operations and the passion that the RoosterBio team shares in their desire to assist tissue engineers and cell therapists to accelerate life-saving technologies into the clinic. Our laser focus coupled with operational excellence has enabled us to reach these milestones; we will delight our customers with our product offering, says Chief Operating Officer, Dr. Uplaksh Kumar. The RoosterBio teams extensive experience sourcing raw materials, manufacturing stem cell products, and controlling for high quality with best-in-class characterization techniques has allowed them to successfully launch their flagship hBM-MSC product quickly and efficiently. Dr. Jon Rowley, RoosterBios Chief Executive said … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on RoosterBio Inc, a Frederick Maryland Biotech Startup, Achieves Rapid Traction with Product Launch and Fundraising …

Renue Aesthetic Surgery – Video

Posted: Published on February 26th, 2014

Renue Aesthetic Surgery By: Victor M Perez … Continue reading →

Posted in Aesthetic Surgery | Comments Off on Renue Aesthetic Surgery – Video

FDA weighs evidence on producing '3-parent' embryos

Posted: Published on February 26th, 2014

U.S. medical advisers are considering whether there is scientific justification for allowing human studies of a controversial procedure known as "three-parent in vitro fertilization (IVF)," a technique supporters say could prevent horrific genetic defects but that critics believe could lead to designer babies. During two days of public hearings starting on Tuesday, scientists were scheduled to present their research to outside advisers to the U.S. Food and Drug Administration. The agency will decide whether safety concerns raised by three-parent IVF are minimal enough to allow clinical trials to begin. The committee is focusing only on the science, and at the end of Tuesday's hearing some committee members expressed concern that animal research cannot yet show that human studies would be safe for women and any children born via the three-parent technique. Several panelists felt "there was probably not enough data in animals . . . to move on to human trials without answering a few additional questions" about safety, said committee chairman Dr. Evan Snyder of the Sanford/Burnham Medical Research Institute in La Jolla, California, in summarizing their views at the end of Tuesday's session. Although the panel has not been asked to consider legal or ethical issues, members of … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on FDA weighs evidence on producing '3-parent' embryos

US FDA weighs evidence on producing 'three-parent' embryos

Posted: Published on February 26th, 2014

NEW YORK - U.S. medical advisors are weighing whether there is scientific justification for allowing human studies of a controversial procedure known as "three-parent in vitro fertilization (IVF)," a technique supporters say could prevent horrific genetic defects, but critics believe could lead to designer babies. Over two days of public hearings starting on Tuesday, scientists were scheduled to present their research to outside advisors to the U.S. Food and Drug Administration. The agency will decide whether safety concerns raised by three-parent IVF are minimal enough to allow clinical trials to begin. The committee is focusing only on the science, not the legal or ethical issues, Celia Witten of the FDA's Office of Cellular, Tissue and Gene Therapies said in comments introducing the hearing. That did not stop members of the public from focusing on ethical issues. Speakers warned the panel that use of three-parent IVF "could alter the human species," represented "an unprecedented level of experimentation on non-consenting human subjects" (meaning any children born via the technique), and "could open the door to genetically-modified children" who would be "manufactured products." In the three-parent procedure, one man would donate sperm and all its DNA for in vitro fertilization. The would-be biological … Continue reading →

Posted in FDA Stem Cell Trials | Comments Off on US FDA weighs evidence on producing 'three-parent' embryos

Making Babies with 3 Genetic Parents Gets FDA Hearing

Posted: Published on February 26th, 2014

A reproductive technology that taps three parents DNA as a way to eliminate hereditary diseases could reach clinical trials if the Food and Drug Administration gives the go-ahead Credit: Thinkstock/iStock Reproductive technologies that marry DNA from three individuals will receive a trial in the court of public opinion this week. Such technologies may hold promise for averting certain genetically inherited diseases passed down via mutations to mitochondria, the cells battery pack. Scientists have already had successes with this type of reproductive approach in monkeys and in human embryos, and are now eager to launch human clinical trials. First, however, they must get the green light from the U.S. Food and Drug Administration, which will convene a public hearing before an advisory committee on February 25. The technology, called oocyte modification (but sometimes nicknamed three-parent IVF), involves scooping out potentially mutated mitochondrial DNA (mtDNA) from a womans egg and replacing it with the mtDNA of an unaffected donor woman. The process is designed to prevent the transmission of some debilitating inherited mitochondrial diseases, which can result in vision loss, seizures and other maladies. Such inherited diseases, often unfortunately known by acronyms for complex medical names that include LHON, for Leber's Hereditary … Continue reading →

Posted in Stem Cell Human Trials | Comments Off on Making Babies with 3 Genetic Parents Gets FDA Hearing

Trevor moves his leg – Video

Posted: Published on February 26th, 2014

Trevor moves his leg Trevor is a C4-5 Quadriplegic. During his stem cell treatment he starts to feel his fingers and feet as well as move his right leg for the first time since h... By: RegenocyteStemCells … Continue reading →

Comments Off on Trevor moves his leg – Video

New Autism Definition May Decrease Diagnosis by One Third

Posted: Published on February 26th, 2014

Contact Information Available for logged-in reporters only Newswise (NEW YORK, NY, February 26, 2014) New diagnosis guidelines for autism spectrum disorder (ASD) issued by the American Psychiatric Association (APA) may reduce by almost one third the total number of people being diagnosed, according to new research from Columbia University School of Nursing published in the Journal of Autism and Developmental Disorders. The guidelines, released in May 2013 and the first major update to psychiatric diagnosis criteria in almost two decades, may leave thousands of developmentally delayed children each year without the ASD diagnosis they need to qualify for social services, medical benefits and educational support. A team led by Kristine M. Kulage, MA, MPH, director of the Office of Scholarship and Research Development at Columbia Nursing, conducted a systematic literature review and meta-analysis to determine the effect of changes to the Diagnostic and Statistical Manual of Mental Disorders (DSM), the APAs classification tool for psychiatric conditions, on diagnosis of individuals with ASD. The study found a statistically significant decrease in ASD diagnosis of 31 percent using the new manual, DSM-5, compared with the number of cases of ASD that would have been identified under the previous version of the manual, … Continue reading →

Comments Off on New Autism Definition May Decrease Diagnosis by One Third

Connolly fan alerted him to possibility he had Parkinson's

Posted: Published on February 26th, 2014

25/02/2014 - 10:00:33Back to Entertainment Home Billy Connolly realised he was suffering from Parkinson's disease after a fan noticed a problem with the way he walked. The 71-year-old star was spotted by an Australian doctor, who was on tour with a group of dancers in America, and he insisted the comedian showed a "strange gait" which led to Billy being diagnosed with the degenerative nerve disorder. Billy told a US radio station: "It was the strangest thing of all. I was walking through the lobby and every time I had gone through there was a crowd of boys and girls and a couple of adults. It turned out they were dancers from Australia. "The guy who was in charge of them came over to me one day and said 'Billy, I'm a big fan, I'm from Tasmania'. "He said, 'I'm a surgeon and I have been watching you walking, you have a strange gait'. That was the way he put it. "He said 'You're showing distinct signs of early onset Parkinson's disease, see your doctor'. I think it was the way I held myself when I was walking. Then they did blood tests and various other little bits and pieces … Continue reading →

Posted in Parkinson's Treatment | Comments Off on Connolly fan alerted him to possibility he had Parkinson's

Windsor Personal Injury Firm Provides Advice on how to Manage Chronic Pain this Winter

Posted: Published on February 26th, 2014

Windsor, Ontario (PRWEB) February 25, 2014 Winter is a difficult time for many people, especially those who suffer from chronic pain syndrome and fibromyalgia. Cold weather and precipitation can exacerbate chronic pain syndrome, fibromyalgia, rheumatoid arthritis, osteoarthritis and other such conditions. Winter can also increase depression levels and depression goes hand in hand with chronic pain. Paciocco & Mellow, a Windsor Personal Injury Firm handles many personal injury claims where people have sustained injuries that led them to suffer from chronic pain syndrome. A recent Austrian study published in the journal, Pain, found that vitamin D supplements may be an effective and inexpensive way of reducing chronic pain and fatigue in patients with fibromyalgia. The participants who took the vitamin D supplements noticed a reduction in pain. Vitamin D supplements could be an economical and safe treatment. A new study from the University of North Carolina School of Medicine, also published in the journal, Pain, found that chronic neck pain is the most commonly reported symptom after a car accident and that after six weeks after a collision, they reported further pain in other regions of the body. Many individuals were hesitant to sue for fear of not being believed. … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Windsor Personal Injury Firm Provides Advice on how to Manage Chronic Pain this Winter

Good reception for Receptos

Posted: Published on February 26th, 2014

Faheem Hasnain, chief executive of La Jolla-based Receptos, with other company members in the lab. For a young biotech company looking to woo investors, it helps to have promising products. Having experienced management helps even more. Receptos, a developer of drugs for autoimmune disorders such as multiple sclerosis, has both. That combination helps explain why shares of the La Jolla company have skyrocketed since it held its initial public offering last May at $14 per share. Even in a surging biotech stock market, the performance of Receptos stands out. Receptos closed Tuesday at $46.39, up $1.97, or 4.4 percent, boosting the companys market value above $1 billion. Those who bought at the IPO price have tripled their investment to date. (During the same time, the Nasdaq Biotechnology Index rose about 56 percent.) Moreover, Receptos held a secondary offering in January. It raised $102 million, compared to $73 million from its IPO. Receptos has good use for the additional money, says its chief executive, Faheem Hasnain. In December, the company released positive results in a mid-stage trial of its drug RPC1063 for multiple sclerosis, a progressively debilitating disease of the central nervous system. The results take much of the risk out … Continue reading →

Posted in MS Treatment | Comments Off on Good reception for Receptos

Page 4,594«..1020..4,5934,5944,5954,596..4,6004,610..»